| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.34 | 0.004 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |